Skip Navigation


JAC Advance Access originally published online on June 13, 2007
Journal of Antimicrobial Chemotherapy 2007 60(2):294-299; doi:10.1093/jac/dkm201
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/2/294    most recent
dkm201v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gant, V. A.
Right arrow Articles by Hall, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gant, V. A.
Right arrow Articles by Hall, T. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Three novel highly charged copper-based biocides: safety and efficacy against healthcare-associated organisms

Vanya A. Gant1,*, Michael W. D. Wren1, Michael S. M. Rollins1, Annette Jeanes1, Stephen S. Hickok2 and Tony J. Hall2

1 Department of Microbiology, University College Hospitals NHS Foundation Trust, London W1T 4JF, UK 2 Remedy Research Ltd, 8 Blenheim Road, London W4 1UA, UK

Received 21 February 2007; returned 24 April 2007; revised 3 May 2007; accepted 10 May 2007


* Corresponding author. Tel: +44-207-380-9912; E-mail: vanya.gant{at}uclh.nhs.uk

Objectives: We investigated three novel highly charged copper-based inorganic biocidal formulations for their activity against organisms highly relevant to healthcare-associated infection.

Methods: The three copper-based formulations were tested: (i) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA), Legionella pneumophila, Acinetobacter calcoaceticus/baumannii (ACCB), glycopeptide-resistant Enterococcus and spores of Clostridium difficile in time–kill assays; (ii) for their ability to decontaminate ultramicrofibre (UMF) cloths; and (iii) for their cytotoxicity to human skin and intestinal epithelial cells.

Results: All three copper-based formulations were potently biocidal down to concentrations of 1 ppm for both stationary- and log-phase organisms, and they were all active against C. difficile spores. At 150 ppm, they achieved a complete (>6 log10) kill of MRSA and ACCB mostly within 1 h. This biocidal activity was not achieved by copper sulphate or the inorganic binders used in the formulations. All three copper-based formulations completely decontaminated UMF cloths containing MRSA, ACCB or C. difficile spores, suggesting that any of these copper-based formulations would be highly beneficial in the healthcare environment. All three copper-based formulations and copper sulphate were not cytotoxic to human epithelial cells up to concentrations of 100–200 ppm.

Conclusions: All three of the novel copper-based biocidal formulations, but not their components (copper sulphate and inorganic binders), have potent activity against organisms highly relevant to healthcare-associated infections.

Keywords: MRSA , Acinetobacter , Clostridium difficile , cytotoxicity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
L. J. Wheeldon, T. Worthington, P. A. Lambert, A. C. Hilton, C. J. Lowden, and T. S. J. Elliott
Antimicrobial efficacy of copper surfaces against spores and vegetative cells of Clostridium difficile: the germination theory
J. Antimicrob. Chemother., September 1, 2008; 62(3): 522 - 525.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
A. Y. Peleg, H. Seifert, and D. L. Paterson
Acinetobacter baumannii: Emergence of a Successful Pathogen
Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.